Pure Bioscience's market cap is currently ―. The company's EPS TTM is $-0.029; its P/E ratio is ―; Pure Bioscience is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Oct 24	Jul 24	Apr 24	Jan 24	Oct 23
Income Statement	-
Total Revenue	$ 556.00K	$ 474.00K	$ 441.00K	$ 326.00K	$ 722.00K
Gross Profit	$ 325.00K	$ 275.00K	$ 258.00K	$ 177.00K	$ 442.00K
EBIT	$ -689.00K	$ -756.00K	$ -816.00K	$ -964.00K	$ -711.00K
EBITDA	$ -689.00K	$ -718.00K	$ -780.00K	$ -927.00K	$ -674.00K
Net Income Common Stockholders	$ -689.00K	$ -756.00K	$ -857.00K	$ -1.00M	$ -735.00K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 346.00K	$ 349.00K	$ 442.00K	$ 557.00K	$ 1.44M
Total Assets	$ 924.00K	$ 818.00K	$ 920.00K	$ 1.09M	$ 2.25M
Total Debt	$ ―	$ ―	$ ―	$ ―	$ ―
Net Debt	$ ―	$ ―	$ ―	$ ―	$ ―
Total Liabilities	$ 4.42M	$ 3.68M	$ 666.00K	$ 2.41M	$ 2.63M
Stockholders Equity	$ -3.50M	$ -2.86M	$ -2.15M	$ -1.32M	$ -383.00K
Cash Flow	-
Free Cash Flow	$ -503.00K	$ -593.00K	$ -615.00K	$ -883.00K	$ -440.00K
Operating Cash Flow	$ -503.00K	$ -593.00K	$ -615.00K	$ -883.00K	$ -440.00K
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	$ 500.00K	$ 500.00K	$ 500.00K	-	$ 785.00K

Currency in USD

Pure Bioscience Earnings and Revenue History

Income Statement >

Pure Bioscience Debt to Assets

Balance Sheet >

Pure Bioscience Cash Flow

Cash Flow >

Pure Bioscience Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing